Safety, Tolerability, and Efficacy of 21 Days Dermal Application of MRX-6 on Mild to Moderate Contact Dermatitis
Clinical trial NCT00867607 · COMPLETED
Trial details
- NCT number
- NCT00867607
- Sponsor
- Hadassah Medical Organization
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2013-04-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.